Rybelsus 14 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F57GH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,804
Award facts
- Contract value 100% obligated
- $27,804.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27.8K delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Rybelsus 14 mg tablets in 30-count units. This non-set-aside, competitively awarded contract carries a firm fixed-price structure with an ultimate completion date of January 12, 2026. The award leverages AmerisourceBergen's existing relationship with DLA and its extensive federal pharmaceutical supply network, which serves critical medical procurement needs across military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an even larger IDC with DLA valued at up to $999,999,999 through December 2031, underscoring the company's significant role in supplying pharmaceutical products and medical commodities to support military healthcare programs worldwide. The Rybelsus delivery order represents one of many task orders executed under these framework agreements to fulfill the Defense Health Agency's prescription medication requirements.
Quick answers
Who was awarded contract SPE2DR26F57GH?
SPE2DR26F57GH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F57GH worth?
The government has obligated $27,804 on SPE2DR26F57GH.
Is contract SPE2DR26F57GH an order under another contract?
Yes. SPE2DR26F57GH is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57GH competed?
The extent of competition for SPE2DR26F57GH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award